Research Papers

25 of 535 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Gaucher Disease for Hematologists
Özdemir GN; Gündüz E.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Does Treatment of Hepatitis C Reduce Inhibitor Titers in Hemophilia A?
Atay MH; Türkoğlu E; Kelkitli E.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Neutrophilic Erythrophagocytosis and Reticulocytopenia: A Rare Manifestation of Cold Autoimmune Hemolytic Anemia
Gupta P; Biswas S; Singh MK; Gupta R.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Spontaneous Remission in Paroxysmal Nocturnal Hemoglobinuria: An Extremely Rare Case
Mehta Ö; Gedük A.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
Hekimoğlu H; Toprak SF; Sözer S.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
Güney T; Can F; Akıncı S; Soyer Kösemehmetoğlu Ö; Dilek İ.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A Crumbled but Fatal Acute Leukemia
Tarantini F; Cumbo C; Specchia G; Musto P; Albano F.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Genetic and Epigenetic Factors Co-Influence the Severity of Phenotypic Presentations in Compound <i>G6PD</i> Mutations
Mot YY; Rajasuriar JS; Fauzi HM; Moses EJ; Yusoff NM.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effe…
Sönmez M; Kestane M; Akıdan O; Erkut N; Bektaş Ö.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A Huge Mass in the Liver: Plasmacytoma
Cinli TA; Yokuş O; Göze H; Erdem Huq G; Serin İ.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma
Kandemir Alibakan Ö; Keskin G; Yılmaz U; Arman Y; Doğan EE; Apaydın Arıkan E.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Pediatric Case of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity
Gündüz M; Tuğcu D; Ünüvar A; Yegen G; Büyükbabani N; Öztürk Sarı Ş.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A Rare Lymphoproliferative Disease: Castleman Disease
Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell Lymphomas: A Case-Con…
Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Ly…
Gupta DG; Varma N; Naseem S; Sachdeva MUS; Bose P; Binota J; Kumar A; Gupta M; Rana P; Sonam P; Malhotra P; Trehan A; Khadwal A; Varma S.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic…
Satırer Ö; Cevher Zeytin İ; Alkan B; Karakaya J; Çetinkaya D; Visal Okur F.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-…
Tombak A; Pepedil Tanrıkulu F; Durusoy SS; Dinçyürek HD; Kaya E; Ümit EG; Yavaşoğlu İ; Mehtap Ö; Deveci B; Özcan MA; Terzi H; Okay M; Sayınalp N; Yılmaz M; Okan V; Kızıklı A; Özcan Ö; Çetin G; Demircioğlu S; Aydoğdu İ; Saydam G; Davulcu EA; İlhan G; Uçar MA; Özet G; Akpınar S; Turgut B; Berber İ; Kurtoğlu E; Sönmez M; Batur DS; Yıldırım R; Özkocamaz V; Güneş AK; Sahip B; Ertop Ş; Akay OM; Baştürk A; Doğu MH; Akdeniz A; Ünal A; Seyhanlı A; Gürkan E; Çekdemir D; Ferhanoğlu B.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Immune Status and Chemokine C Receptor 7 Expression in Primary in Patients with Immune Thrombocytopenia
Zhang L; Zhou GZ; Feng WY; Li D.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute My…
Zhai H; Zhao J; Pu J; Zhao P; Wei J.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Severe Lymphocytosis in a Case of Diffuse Large B-Cell Lymphoma Treated by Ibrutinib
Paydaş S; Bayram E; Türker M; Özer T.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on E…
Baysal M; Baş V; Ümit E; Kırkızlar HO; Demir AM.
Turk J Haematol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Sweet Syndrome Associated with Ixazomib
Yavaşoğlu İ; Bolaman Z.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Shoulder-Pad Sign in a Case of Amyloidosis Associated with Myeloma
Uzunoğlu C; Toptaş T; İpek Y; Arıkan F; Yılmaz F; Tuğlular T.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia
Cheng C; Mi R; Li D; Chen L; Wei X.
Turk J Haematol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared